Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes

Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes

US Patent 11192942 · Granted Dec 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cell-free glycoprotein synthesis (CFGPS) in prokaryotic cell lysates enriched wi2025
Bioconjugate vaccines' synthesis in prokaryotic cell lysates2025
Method for rapid in vitro synthesis of glycoproteins via recombinant production 2025
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines i2025
Method for rapid in vitro synthesis of glycoproteins via recombinant production 2023
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines i2022
Cell-free glycoprotein synthesis (CFGpS) in prokaryotic cell lysates enriched wi2022
Prokaryote-based cell-free system for the synthesis of glycoproteins2021
Nucleic acids, vectors, host cells, and methods for recombinantly producing wate2021
Subunit vaccine delivery platform for robust humoral and cellular immune respons2021
Method for rapid in vitro synthesis of glycoproteins via recombinant production 2020
Subunit vaccine delivery platform for robust humoral and cellular immune respons2020